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A B S T R A C T
PRRS is among the diseases with the highest economic impact in pig production worldwide. Diﬀerent strategies
have been developed and applied to combat PRRS at farm level. The broad variety of available intervention
strategies makes it diﬃcult to decide on the most cost-eﬃcient strategy for a given farm situation, as it depends
on many farm-individual factors like disease severity, prices or farm structure. Aim of this study was to create a
simulation tool to estimate the cost-eﬃciency of diﬀerent control strategies at individual farm level. Baseline is a
model that estimates the costs of PRRS, based on changes in health and productivity, in a speciﬁc farm setting
(e.g. farm type, herd size, type of batch farrowing).
The model evaluates diﬀerent intervention scenarios: depopulation/repopulation (D/R), close & roll-over (C&
R), mass vaccination of sows (MS), mass vaccination of sows and vaccination of piglets (MS+piglets), im-
provements in internal biosecurity (BSM), and combinations of vaccinations with BSM. Data on improvement in
health and productivity parameters for each intervention were obtained through literature review and from
expert opinions. The economic eﬃciency of the diﬀerent strategies was assessed over 5 years through investment
appraisals: the resulting expected value (EV) indicated the most cost-eﬀective strategy. Calculations were per-
formed for 5 example scenarios with varying farm type (farrow-to-ﬁnish – breeding herd), disease severity
(slightly – moderately – severely aﬀected) and PRRSV detection (yes – no). The assumed herd size was 1000 sows
with farm and price structure as commonly found in Germany. In a moderately aﬀected (moderate deviations in
health and productivity parameters from what could be expected in an average negative herd), unstable farrow-
to-ﬁnish herd, the most cost-eﬃcient strategies according to their median EV were C&R (€1′126′807) and
MS+piglets (€ 1′114′649). In a slightly aﬀected farrow-to-ﬁnish herd, no virus detected, the highest median EV
was for MS+piglets (€ 721′745) and MS (€ 664′111). Results indicate that the expected beneﬁts of interven-
tions and the most eﬃcient strategy depend on the individual farm situation, e.g. disease severity. The model
provides new insights regarding the cost-eﬃciency of various PRRSV intervention strategies at farm level. It is a
valuable tool for farmers and veterinarians to estimate expected economic consequences of an intervention for a
speciﬁc farm setting and thus enables a better informed decision.
1. Introduction
A multitude of studies have conﬁrmed the vast economic impact of
Porcine Reproductive & Respiratory Syndrome (PRRS) on pig produc-
tion in many countries all over the world (Holck and Polson, 2003;
Holtkamp et al., 2013; Neumann et al., 2005; Nieuwenhuis et al., 2012;
Pejsak and Markowska-Daniel, 1997). The detrimental eﬀect of the
disease is caused by the fact that it impairs performance at several
stages of production. Not only does it aﬀect the number of piglets
weaned due to increased abortion rates, lower numbers of piglets born
alive or a higher pre-weaning mortality; it also leads to increased
mortality rates and a reduced growth rate and feed eﬃciency in nursery
and grower pigs (Neumann et al., 2005; Nieuwenhuis et al., 2012;
Olanratmanee et al., 2013). Furthermore, the eﬀects described in these
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studies were not only restricted to the period of the acute outbreak, but
persisted for a considerable period thereafter.
Lots of eﬀort has been undertaken to ﬁnd ways of how to control
PRRSV infection. At farm level, various strategies have been developed
and applied in the ﬁeld to combat PRRS. One approach is to eliminate
the virus and create a completely virus-negative herd. Three diﬀerent
methods are commonly applied to achieve this aim. The ﬁrst possibility
is complete herd depopulation and repopulation. This comprises the
slaughter or culling of all pigs present at the farm, followed by a re-
stocking with PRRSV-negative animals. While this measure is highly
eﬀective, its costs are very high (Corzo et al., 2010). A second and ra-
ther cheap method is herd closure and roll-over. The introduction of
new and thus naïve animals that were never exposed to the (farm-)
speciﬁc strain of PRRSV is stopped, resulting in no susceptible animals
at one time point and ceased virus transmission (McCaw et al., 2003).
The third option is test and removal, where all adult animals are tested
and all PRRSV seropositive animals are culled (Dee and Molitor, 1998),
making this strategy considerably costly. Besides elimination proce-
dures, various vaccines are on the market to control PRRS. While the
protection provided by commercially available inactivated vaccines is
currently considered low (Renukaradhya et al., 2015), modiﬁed live
vaccines (MLV) have successfully reduced clinical impact of PRRSV
infection in breeding as well as growing animals, with positive eﬀects
e.g. on the number of piglets born alive, mortality in suckling and
weaning pigs or average daily weight gain (Alexopoulos et al., 2005;
Cano et al., 2007; Kritas et al., 2007; Olanratmanee et al., 2014; Scortti
et al., 2006). Vaccination protocols usually comprise the immunization
of gilts and subsequent vaccination of sows, either in the form of a mass
vaccination in intervals of three or four months, or according to the
status of reproduction, most commonly at day 6 after farrowing and at
day 60 of gestation. Complementary vaccination of suckling pigs is
usually done at two to three weeks of age to reduce shedding/circula-
tion of the virus and improve production parameters from wean to
ﬁnish (Kritas et al., 2007). Since many factors related to farm internal
processes like pig ﬂow, biosecurity, hygiene etc. were proven to play an
important role in intra-herd virus transmission and thus the clinical
presentation of PRRS in an infected herd (Young et al., 2010), these can
also be adjusted for PRRSV control. Related concepts are e.g. an opti-
mized gilt acclimatization (Corzo et al., 2010) or procedures to reduce
virus transmission in suckling pigs like “McRebel” (McCaw, 2000).
This broad variety of available intervention strategies makes it
diﬃcult to decide which strategy is most appropriate in a given farm
situation. Some strategies make sense only under certain circumstances:
e.g. test & removal is recommended in sow herds with a low ser-
oprevalence and no acute outbreak history within the past twelve
months (Zimmerman et al., 2012). Other strategies are extremely ef-
fective but at the same time very expensive, like depopulation-re-
population. This means that farmer and veterinarian need to consider
not only the expected eﬀect or success of a measure, but also the costs,
and it is not necessarily the most eﬀective measure that turns out to be
the most economically eﬃcient one. Many diﬀerent farm-individual
factors like the degree of clinical severity but also the price situation (be
it the generated revenue, current expenses or costs of intervention
strategies) have an impact on the cost eﬃciency and the return on in-
vestment of each strategy in a given farm. Until to date, the decision
which strategy ﬁts best in a certain farm was often based on a veter-
inarian’s (personal) experience and “gut feeling”, as objective tools for
decision making have not been available. Thus, aim of this study was to
create a simulation tool to systematically evaluate the economic eﬃ-
ciency of diﬀerent common PRRSV intervention strategies in en-
demically aﬀected farms for diﬀerent farm situations over a period of
ﬁve years. This tool is intended to be a decision-making tool for ve-
terinarians on the most appropriate intervention strategy for a given
PRRSV aﬀected farm. The tool is made available via the “PRRS in-
tegrated solutions” website and smartphone app (Merck Animal Health,
New Jersey, United States of America).
2. Material and methods
The methodology used is similar to an economic model for post-
weaning multi-systemic wasting syndrome created by Alarcon et al.
(2013) and is based on a stochastic spread sheet model that estimates
the cost of PRRS of an infected farm developed by Nathues et al. (2017)
as a baseline.
2.1. Summary of the PRRS herd-level cost model used as baseline
This baseline model estimates the farm-level yearly PRRS losses for
ﬁve diﬀerent production systems: (1) breeding farms with sale of piglets
at weaning; (2) breeding farms with sale of nursery pigs; (3) nursery
farms, (4) fattening farms; and (5) farrow-to-ﬁnish farms. The model
consists of three parts: breeding, nursery and fattening part, and their
diﬀerent combinations are used to make up the 5 production systems
investigated. Since this model was designed as a calculator for farmers
and veterinarians, it can be customized to other farm speciﬁc settings,
e.g. the type of batch farrowing (one-week- and three-week-rhythm)
and the length of the suckling period (three, four and ﬁve weeks), as
well as production performance, disease parameters and prices.
Through a literature review process, PRRS epidemiological and pro-
duction impact parameters were identiﬁed and their values assessed.
With this, a production model was created that simulates the changes in
population dynamics and pig management parameters (i.e. feed con-
sumption) between a PRRS diseased and non-diseased (i.e. PRRSV-ne-
gative) farm scenario on a yearly basis, with the underlying assumption
that PRRSV is the cause of these changes in health and performance
parameters. This production model is supplemented by an economic
model to assess the farm’s proﬁtability through gross margin and en-
terprise budget analyses, and to calculate the net losses from PRRS via
partial budget analyses. Full details and parameters can be found in
Nathues et al. (2017).
This baseline cost-model was extended by incorporating diﬀerent
intervention strategies. Firstly, the two most commonly applied elim-
ination procedures were considered: 1) depopulation/repopulation and
2) close & roll-over. Secondly, two widely used vaccination protocols
were included: 3) mass vaccination of sows, 4) mass vaccination of sows
and vaccination of piglets. Lastly, 5) the improvement of (internal)
biosecurity and management was evaluated alone and, 6) & 7), in
combination with the two vaccination protocols.
2.2. Example herd and example scenarios
We would like to demonstrate the application of the model pre-
senting estimations for diﬀerent farm and disease situations. These are
based on the following general farm characteristics, which can be seen
as typical for e.g. the pig-dense parts of Germany: a sow herd with 1000
working sows, a one-weekly production rhythm (i.e. batch-wise far-
rowing every week), three weeks of suckling period, an annual re-
placement rate of 35%, selling nursery pigs at 30 kg live weight
(breeding herd) or ﬁnishers at 120 kg live weight (farrow-to-ﬁnish
herd). Due to the one-weekly farrowing rhythm, the farm has 21 sow
groups, 7 diﬀerent age groups of nursery pigs and 17 diﬀerent age
groups of fatteners (depending on the length of nursery and fattening
period). The economic eﬃciency of intervention strategies was assessed
for ﬁve diﬀerent scenarios, the details of which are listed in Table 1: we
accounted for two diﬀerent herd types: farrow-to-ﬁnish herd or
breeding herd with sale of nursery pigs; two diﬀerent vaccination his-
tories: no current vaccination or mass vaccination of sows; virus de-
tection: ﬁeld virus detected within the previous twelve months or no
ﬁeld virus detected within the previous twelve months. Whereas in the
positive case (virus detected) this corresponds to category “unstable”
according to Holtkamp (Holtkamp et al., 2011), in the negative case,
the herd cannot necessarily be classiﬁed as sustainably stable; it rather
indicates that PRRSV circulation has been at low levels. Lastly, we
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assumed diﬀerent degrees of disease severity: slightly or moderately
aﬀected in breeding, nursery and/or fattening (determined by the va-
lues of performance and disease parameters in the respective farm
part). Scenario 1 is a farrow-to-ﬁnish herd that does not currently
vaccinate against PRRS. No ﬁeld virus has been detected in any of the
production parts within the previous year, associated with only slight
clinical aﬀectedness in all farm parts. Scenario 2 diﬀers from the ﬁrst in
that ﬁeld virus was detected in all farm parts, associated with moderate
aﬀectedness in all farm parts. In scenario 3, sows are vaccinated against
PRRSV, so that ﬁeld virus detection and clinical aﬀectedness are con-
ﬁned to the later stages of production (nursery and fattening: moder-
ately aﬀected). Scenario 4 is a breeding herd, where the focus of PRRSV
impact is in the breeding part (ﬁeld virus detected in suckling piglets,
moderately aﬀected), whereas no eﬀect is seen in nursery. In scenario 5,
the breeding herd is vaccinating sows, and PRRSV activity is at low
level (no virus detection) but not “0” (slight clinical aﬀectedness) in
both breeding and nursery part.
2.3. Description of considered intervention strategies
1) Depopulation/repopulation (D/R)
Upon start of the intervention (day 0= one day before the next
regular insemination of a sow batch), the farmer stops breeding the
sows and instead sends all of them to slaughter as soon as their piglets
are weaned. Once the piglets from the last batch of sows are weaned,
the farmer sells all remaining animals of the herd, accepting that some
batches are sold prematurely i.e. with underweight. After thorough
cleaning and disinfection of all facilities and an empty period of at least
6 weeks, the farmer starts repopulating the herd batch-wise with
PRRSV-negative gilts, so that the ﬁrst batch of new gilts will be bred
around two weeks later, the ﬁrst batch of piglets will be weaned
roughly one year after start of the intervention, and slaughtered
roughly in the middle of the second year (all depending on the length of
suckling, nursery and fattening period).
2) Close & roll-over (C&R)
On day 0, the farmer purchases the number of gilts that will be
needed for replacement during the next six months, precisely in ﬁve
diﬀerent age groups from 75 days of age to 159 days of age. From this
day onwards he will not introduce any animals from outside into the
herd for a period of six months. To provide simultaneous exposure of all
sows at the beginning of herd closure, all sows are vaccinated once with
a MLV.
3) Mass vaccination of sows (MS)
After basic immunization of all sows and a booster vaccination four
weeks later, the regular protocol comprises the vaccination of the whole
sow herd every three months. Incoming gilts are vaccinated twice
during acclimatization.
Table 1
Farm characteristics and performance/disease parameters for ﬁve diﬀerent farm/disease scenarios (ftf= farrow-to-ﬁnish herd; brn= breeding herd with nursery pigs; light grey coloured
cells indicate slight aﬀectedness, darker grey coloured cells moderate aﬀectedness), and baseline values to characterize a healthy PRRSV-negative farm (in italic).
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4) Mass vaccination of sows and vaccination of piglets (MS+ piglets)
Vaccination of sows is as described under strategy 3); piglets are
regularly vaccinated once at day 12–21 after birth.
5) Improvement of (internal) biosecurity and management (BSM)
This intervention comprises a set of diﬀerent single measures,
mainly but not only concerning internal biosecurity, which should be
implemented depending on the current situation on the farm. These
could be:
• Strict all-in-all-out regime in farrowing, nursery and fattening units
with proper cleaning and disinfection.
• Appropriate gilt acclimatization.
• No cross-fostering of suckling pigs> 24 h after birth.
• Change of injection needles at least between litters.
• Facilities to separate sick animals from others.
• Segregated early weaning.
• Treatment of co-infections.
• Gilts/boars/semen from certiﬁed PRRS-negative sources (external
biosecurity).
• Tn the case of nursery or fattening farms purchase of vaccinated
piglets (external biosecurity).
The herd-attending veterinarian decides on what measures need to
be implemented after thorough herd examination and identiﬁcation of
the weak points requiring improvement. Goal is that biosecurity and
management processes are optimized to a level appropriate for the farm
system.
6) BSM in combination with mass vaccination of sows (MS+BSM)
This intervention strategy is a combination of measures 3) and 5).
7) BSM in combination with mass vaccination of sows and vaccination
of piglets (MS+piglets+ BSM)
This intervention strategy is a combination of strategy 4) and 5).
2.4. Eﬀect of interventions on herd performance and PRRS disease
parameters
2.4.1. Degree of improvement
For the two elimination procedures, it is assumed that the herd will
become PRRSV-negative (no detection of virus, in the case of 2) C&R
termed “provisionally negative” according to Holtkamp (Holtkamp
et al., 2011) after completion of the intervention. Thus, all performance
and disease parameters will return to baseline values that can be ex-
pected in an average healthy farm. These baseline values originating
from industry reports (see Nathues et al., 2017) are given in Table 1.
In contrast, vaccination protocols and BSM will most likely not re-
sult in a complete elimination of the virus and cessation of clinical
signs, but rather in a certain degree of improvement in the PRRSV-
aﬀected performance and disease parameters. Value distributions for
improvement per strategy and parameter are shown in Table 2. For the
strategy relying on sow vaccination only (3), improvements are as-
sumed to take place only in breeding and nursery part. For the vacci-
nation protocol also involving piglets (4) and 5) BSM, improvements
are also expected in the fattening part. Furthermore, as concluded from
Table 2, relative improvement is assumed to be stronger, if ﬁeld virus
had been detected in the farm part (separately for breeding, nursery
and fattening), corresponding to category “unstable” (Holtkamp et al.,
2011). Also, a stronger improvement for strategy 4) is assumed, if the
farm does not vaccinate at all against PRRSV at the time of assessment.
As scientiﬁc literature did not have enough information on the
degree of improvement on single parameters for each intervention, an
expert poll was conducted. An online questionnaire was created in
LimeSurvey software (LimeSurvey Project Hamburg, Germany), and
was sent via e-mail to 42 experts (comprising Diplomates of the
European College of Porcine Health Management, experts of the
EuPRRS.net panel and selected European and US-American pig experts
from science and industry/private practice). The survey asked the ex-
perts to which level a certain parameter (e.g. abortion rate, piglets born
alive, PRRS morbidity) would improve, compared to its current status,
if strategy 1) – 6) were implemented. Answers were received from
eleven participants. For each question, minimum, median and max-
imum values were calculated for all answers. These values formed the
base to parametrize PERT distributions indicating the degree of im-
provement for each performance and disease parameter and each in-
tervention strategy (see Table 2 and section ‘Stochasticity’). For the
combined strategies 6) & 7), the level of improvement for each para-
meter was calculated as the product of the values of improvement of
each strategy alone: e.g. if 3) MS alone reduces the PRRS morbidity to
80% of its current status and 5) BSM alone to 90%, the combined
strategy 6) will result in an improvement to 72%.
2.4.2. Probability of success
Besides the level of improvement, the probability of success, i.e. the
probability that the anticipated improvement is achieved, determines
the value of an intervention strategy. For 1) D/R, given that the mea-
sure is carried out correctly, it is believed that the probability of suc-
cess, i.e. that the strategy will lead to complete elimination of the virus
from the farm, is 100%. For 2) C&R, this probability is assumed less
than 100%. The corresponding probability distribution was obtained
from literature review and expert opinion, see Table 3. Distributions or
ranges for vaccination and BSM strategies, where improvement is less a
question of “all or nothing” but exhibits variability between and within
parameters – expressed as distributions – already incorporate a prob-
ability of success. Therefore, a probability of success as separate factor
was not necessary to be accounted for, and thus was set to 100%.
2.5. Applicability of strategies
Since it does not make sense to evaluate every strategy for every
possible farm situation, the following assumptions and restrictions were
made: Elimination procedures are only applicable to herds holding
sows, not for specialized nursery or fattening farms. Strategy 3) MS is
only evaluated if at the time of assessment the farm does not vaccinate
against PRRSV. Strategy 4) MS+piglets is evaluated if the farm does
not vaccinate at all against PRRSV or if, at the time of assessment, it
vaccinates only sows. The same applies to combinations of vaccination
and BSM.
2.6. Economic modelling of each intervention strategy
A separate production model is calculated for the farm at its current
status as well as for each intervention strategy to reﬂect the situation
after completion of the intervention, i.e. the ﬁnal status.
2.6.1. Final status
In the production models for the elimination procedures, the base-
line performance and disease parameters in Table 1 are used. In the
models for the other intervention strategies, the current values of dis-
ease and performance parameters are multiplied by the expected degree
of improvement as indicated in Table 2. As an example, a current
abortion rate of 15% will decrease to a median of 10.5% (70% of its
current value) after implementing strategy no. 3) mass vaccination in
sows. A current weight at weaning of 5 kg will increase to a median of
5.75 kg (115% of its current value) following implementation of 4)
MS+piglets. However, the model does not allow the achieved im-
provement to exceed the baseline value as deﬁned for a negative farm:
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e.g. if the current weaning weight is 5.5 kg and the baseline value for a
negative farm is 6 kg, strategy 4) will return the weight to 6 kg and not
6.33 kg, which equals 115%. These calculations will result in the dif-
ferent production outputs for each intervention, e.g.: the number of
sows slaughtered, the number of piglets weaned, nursery pigs sold and
ﬁnisher pigs slaughtered, the number of inseminations or kg feed
needed, the number of diseased or died animals, and so on, per batch
and year.
The outputs of the production models are used to conduct a series of
gross margin analyses (GM) as well as enterprise budget analyses (EB)
to assess revenue, variable costs and ﬁxed costs of producing (a) a batch
of pigs under the current disease status and (b) a new batch of pigs in
the ﬁnal status for each type of intervention per batch and per year,
using the same methodology as described in Nathues et al., 2017. The
subsequent partial budget analysis then indicates extra losses and
beneﬁts per batch and per year for each intervention strategy in com-
parison with the current status of the aﬀected farm (Eq. (1)).
= +
− +
Partial budget PB cost saved extra revenue
extra cost revenue foregone
( ) ( )
( ) (1)
This calculation also incorporates intervention-speciﬁc costs oc-
curring after completion of the intervention; so these are the costs in-
curring regularly throughout the whole period of observation:
2.6.1.1. Costs related to elimination strategies. Farms that implemented
strategy 1) or 2) will in most cases have to increase their levels of
external biosecurity to minimize the risk of PRRSV re-introduction.
This is likely an extra cost. To account for this fact, a small proportion
of the total current cost is added to the calculated costs of a farm after
elimination (value given in Table 3).
2.6.1.2. Costs related to vaccination strategies. Regular costs for
strategies 3) and 4) consist of vaccination costs according to the
vaccination protocol (used prices per dose see Table 4): for the mass
vaccination of sows every three months, the required number of doses
per year corresponds to four times the total number of sows. Further
costs comprise the vaccination of all incoming replacement gilts twice
during acclimatization. For piglet vaccination, the number of doses
required corresponds to the number of piglets weaned per year (it is
assumed that most of the suckling pig mortality occurs in the ﬁrst days
of life, so that piglets reaching vaccination age will also reach the
weaning age). Total costs for strategy 4) depend on the current
Table 2
Minimum (Min), most likely (ML) and maximum (Max) values for the degree of improvement in each performance and disease parameter for intervention strategies 3) – 5), as derived
from expert opinion and used in PERT-distributions.
Intervention strategy/parameter Change to (%)
Min ML Max Min ML Max
3) Mass vaccination of sows
non-conception rate 100% 80% 20%
abortions 99% 70% 10%
average piglets born alive per sow per litter 101% 120% 170%
pre-weaning mortality 100% 70% 10%
weight at weaning (kg) 100% 115% 180%
weaners clinically aﬀected by PRRS 100% 80% 30%
weaners mortality 100% 90% 20%
ADG weaning to sale (kg) 100% 110% 170%
4) Mass vaccination of sows and vaccination of piglets With previous sow vacc. No previous vacc.
non-conception rate 100% 80% 20% 100% 80% 20%
abortions 99% 70% 10% 99% 70% 10%
average piglets born alive per sow per litter 101% 118% 170% 101% 120% 170%
pre-weaning mortality 100% 73% 10% 100% 70% 10%
weight at weaning (kg) 100% 115% 180% 100% 115% 180%
weaners clinically aﬀected by PRRS 95% 80% 30% 99% 80% 30%
weaners mortality 96% 85% 20% 99% 85% 20%
ADG weaning to sale (kg) 104% 110% 170% 102% 110% 170%
fatteners clinically aﬀected by PRRS 100% 90% 50% 100% 90% 50%
Fatteners mortality 100% 95% 50% 100% 96% 50%
ADG fatteners until sale (kg) 100% 109% 150% 100% 108% 150%
5) Improvement of internal biosecurity and management Virus detected No virus detection
non-conception rate 97% 80% 20% 100% 85% 20%
abortions 99% 80% 10% 99% 90% 10%
average piglets born alive per sow per litter 101% 120% 170% 101% 110% 170%
pre-weaning mortality 98% 70% 10% 100% 90% 10%
weight at weaning (kg) 100% 110% 180% 100% 105% 180%
weaners clinically aﬀected by PRRS 100% 390% 30% 100% 90% 30%
weaners mortality 100% 90% 20% 100% 90% 20%
ADG weaning to sale (kg) 100% 110% 170% 100% 110% 170%
fatteners clinically aﬀected by PRRS 100% 90% 50% 100% 90% 50%
Fatteners mortality 100% 95% 50% 100% 95% 50%
ADG fatteners until sale (kg) 100% 108% 150% 100% 105% 150%
Table 3
Parameters relevant for speciﬁc interventions including their minimum (Min), most likely
(ML) and maximum (Max) values, to parametrize PERT-distributions.
Strategy/parameter Min ML Max Reference
2) Close & roll-over
% of sows that drop out because they do
not meet the selection criteria
10% 20% 25% assumption
Average live weight of a sow that drops out
kg
105 110 115 assumption
Probability of success 30% 85% 95% expert opinion
Strategies 1) & 2)
% permanent increase in total costs for
permanently improved external
biosecurity after virus elimination from
herd
0.1% 1% 5% expert opinion
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vaccination scheme: For herds without PRRS vaccination, additional
costs consist of costs for sow and piglet vaccination, whereas for herds
already vaccinating sows, only costs for piglet vaccination will be
counted as additional costs.
2.6.1.3. Costs related to BSM. Regular costs related to strategy 5) are
the costs for permanently improving internal biosecurity and
management. Here, the level of expenditure very much depends on
the measures necessary in a given farm, and it is assumed that these
measures involve rather long-term and recurring than just one-time
costs. Therefore, the farmer or veterinarian is asked to indicate his/her
estimate of the regularly accruing BSM-related expenses as a percentage
of the current total costs, which will be added to the current costs
(percentage used in this example in Table 4).
2.6.1.4. Costs related to combined strategies. Regular costs for 6) and 7)
combine the costs for vaccination with the BSM-related expenses as
described under 3) – 5).
The diﬀerence obtained in EB net margins between current status
and intervention represents the total net beneﬁt or loss due to an in-
tervention, i.e. “net value of change” per year in the ﬁnal status, once
the intervention is completed and the ﬁnal level of improvement
reached.
However, for all intervention strategies, a transition phase needs to
be accounted for, in which the intervention is being implemented but
not yet eﬀective: during this time period, there will be no improvement
in the disease and performance parameters yet, and temporary changes
or disruptions in production processes as well as one-time costs or costs
diﬀerent from those in the ﬁnal status will occur. Therefore, the yearly
production models for the ﬁnal status cannot be applied one-to-one for
this transition period. As a consequence, two separate partial budget
calculations are needed for each intervention: one for the transition
phase and one for the years in the ﬁnal status after completion of the
intervention. Since it was assumed that the intervention procedure
should be completed at some point in time within the ﬁrst year after its
initiation, the ﬁrst year was deﬁned as transition period. Consequently,
the calculated net value of change described for the ﬁnal status applies
to the years 2–5 of the observation period. An exception is strategy 1)
D/R, where the transition period was set to two years, because it takes
more than one year until ﬁrst new batch produced is sold for slaughter
(see section “Example herd and example scenarios”).
2.6.2. Transition period
For the transition period, a separate series of partial budget analyses
is performed to assess the extra cost, revenue foregone, cost saved and
extra revenue of implementing the intervention for each batch in the
ﬁrst year: for this purpose, the batch production, i.e. the numbers of
batches produced every week in the ﬁrst – and for 1) D/R also the
second – year is simulated in a mathematical model (see Supplementary
material S1). Day 1 in the model corresponds to the day of insemination
of a sow group. The day when a batch is weaned, leaves the nursery or
is sold for slaughter depends on the suckling period, the number of days
in nursery and the number of days in fattening. This simulation, besides
the number of sow batches inseminated since the start of the inter-
vention, ﬁrstly indicates the number of old batches weaned, old nursery
batches and old batches sold for slaughter. “Old” designates the batches
produced before the intervention i.e. the related improvements become
eﬀective. Secondly, the simulation indicates the number of new batches
weaned, new nursery batches and new batches sold for slaughter.
“New” relates to the batches that are produced after the intervention
has become eﬀective and where the ﬁnal, improved performance is
reached. The dates from which these new batches occur depend on the
calculated new, i.e. lower numbers of days in nursery and fattening. The
switch from old to new batches is assumed to take place gradually: the
ﬁrst new batch weaned will some weeks later become the ﬁrst new
nursery batch and again some weeks later the ﬁrst new batch sold for
slaughter (see following description of each intervention strategy).
Since in 1) D/R, some batches are sold prematurely and thus under-
weight, the number of “unﬁnished” nursery and fattening batches sold
is simulated as well. Furthermore, since this measure requires a tem-
porary complete cessation of production, the number of batches missed
in the transition period is calculated as the diﬀerence to the number of
batches that would have been produced in the same time if no inter-
vention had taken place.
With the so-derived number of batches, the new costs, costs saved,
extra revenue and revenue foregone are ﬁrst calculated separately i) for
the old, unﬁnished or missed batches and ii) for the new batches. For
the new batches, this is simply the net value as derived from batch-wise
partial budgets of the ﬁnal status. For the old, unﬁnished or missed
batches, the costs and revenue are described for each intervention
strategy in the next section. The total net value of partial budget ana-
lysis (NVPBA) of the transition period, i.e. the ﬁrst (and second) year, is
then as follows (Eq. (2)):
= +NVPBA NVPBA NVPBA
No ofnewbatches* .
transition old unfinished missedbatches batchinfinalstatus
transition
/ /
(2)
The outcomes of the batch simulation model and cost calculations
for each intervention are explained in the following section, the equa-
tions used in the cost calculations can be found in the Supplementary
material (S1).
2.6.2.1. Depopulation/repopulation (D/R). The start of the intervention
(day 1) is when the ﬁrst sow batch that would be due for breeding on
that day will not be inseminated (see three-weekly batch simulation in
Supplementary material S2). In our example herd, the farmer weans the
Table 4
One-time and recurring costs for the diﬀerent intervention strategies used in the example.
Intervention/cost Value Reference
Strategies 1) & 2)
Price of a replacement gilt 350.00 € Anonymous (2015)
Cleaning and disinfection after depopulation/sow (incl. water, energy, chemicals etc.) 10.00 € assumption
Extra labour cost/sow during depop./repop. Procedure 30.00 € assumption
Transport cost/sow 5.00 € Anonymous (2015)
2) Close & roll-over
Extra cost (building etc.) for providing space to all replacement gilts needed for the following 6 months (time period of herd closure)/sow 30.00 € assumption
Discount from regular price for the purchase of younger gilts, % per 3 weeks younger age (baseline=180 days) 1% assumption
Strategies 3) – 7)
Price per dose PRRS vaccination (sow) incl. labour 1.00 € Linhares et al. (2015)
Price per dose PRRS vaccination (piglet) incl. labour 0.80 €
5) Improvement of internal biosecurity and management
Overall% permanent increase in total costs for permanently improving internal biosecurity and management 2% expert opinion
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last batch of piglets on day 134 and depopulates the herd. This means
that from the start of the intervention until this day, 20 old batches
have been weaned, gone into nursery and have been sold for slaughter.
Taking scenario 2 with on average 50 nursery days and 127 fattening
days before the intervention as an example, there will be seven age
groups (=batches) of nursery pigs and 18 age groups (=batches) of
fattening pigs present at the farm on the day of depopulation. These will
have to be sold unﬁnished. Roughly 8 weeks later (day 190), the ﬁrst
new gilts are bred, and thus the ﬁrst new batch of piglets will be
weaned around day 326. With the now shorter nursery period (45 days)
they enter the nursery at around day 371 and are sold for slaughter
after 119 days around day 490 in this example. This means that during
the transition period of two years, in the given example, according to
S2, there will be a total of 57 new batches weaned (and 25 missed to
produce), 51 new nursery batches (24 missed to produce) and 34 new
batches sold for slaughter (33 missed to produce).
Extra costs associated with the transition phase include transport
costs of all sows to slaughter, the complete re-stocking of the herd
with PRRSV-negative gilts, cleaning and disinfection and extra la-
bour costs (prices used in Table 2, further details on calculations of
extra costs in Supplementary material S1).
Extra revenue is generated by the slaughter of all sows (see also
S1).
Costs saved during the empty period include costs for breeding,
feed, water, veterinary, labour, disposal, transport and energy in
the breeding unit (for prices of general farm costs see Nathues et al.
(2017) and S1); furthermore feed, water, labour, energy and trans-
port costs saved for nursery batches and fattening batches that are sold
with underweight (unﬁnished batches), based on age and weight at
which they are sold, and batches missed to produce (see S1).
Revenue foregone for unﬁnished batches is calculated based on
age and weight at which they are sold, and for batches missed to
produce during the empty period. (see S1)
2.6.2.2. Close & roll-over (C&R). Since it was assumed that the
intervention becomes eﬀective after the six months period of herd
closure, the change from old to new batches happens around day 180,
which is when the ﬁrst new batch is weaned (see S2). This will become
the ﬁrst new batch of nursery pigs 45 days later and the ﬁrst new batch
sold for slaughter 119 days later. In the example of scenario 2 this
would result in a total of 25 old batches weaned, 32 old nursery
batches, 51 old batches sold for slaughter and 27 new batches weaned,
21 new nursery batches and four new batches sold for slaughter during
the ﬁrst year.
Extra costs include extra feed, water, labour, energy, treatments
etc. for the gilts needed for the period of herd closure, depending on the
number of extra days spent on the farm compared with the normal age
at entrance. A higher number of gilts have to be bought, due to a
higher percentage of drop-outs of negatively selected gilts if purchased
at a younger age. This means transport costs for sending these gilts to
slaughter (extra percentage and average weight at which drop-outs will
be sold for slaughter in Table 3). The provision of space for the nu-
merous gilts arriving at the same time might require structural mod-
iﬁcations to the facilities. Lastly, all sows will receive a MLV vacci-
nation once (assumed costs in Table 4). Costs saved occur because of
lower prices for younger gilts (applied price discount in Table 4).
Extra revenue incurs for the slaughter of drop-out gilts (for details on
calculations see S1).
2.6.2.3. Mass vaccination of sows (MS). The strategy is supposed to
become eﬀective approximately two to three weeks after the second
vaccination, when immunity has fully developed in sows and will be
transferred to new-born piglets. The ﬁrst new batch will consequently
be weaned at around day 72, go to fattening around day 107 and be
sold to slaughter at day 239. The calculation of the number of batches is
conducted in the same way as shown for strategy 1) and 2) in S2, and in
our farm scenario 2, this means 43 new batches weaned, 37 new
nursery batches and 19 new fattening batches sold for slaughter.
Extra costs comprise the basic immunization and a second vacci-
nation of all sows (cost per dose see Table 4, calculations see S1).
2.6.2.4. Mass vaccination of sows and vaccination of piglets
(MS+ piglets). The strategy is supposed to become eﬀective once all
batches of nursery pigs present at the farm are vaccinated pigs, i.e. at
around day 53. In scenario 2, the number of new batches weaned will
be 45, new nursery batches 39 and new batches sold for slaughter 22.
Extra costs, if the herd does not vaccinate any animals, are com-
posed of twice the vaccination of sows as described above and the
vaccination of suckling pigs (price see Table 4); otherwise only the
vaccination costs for piglets (calculations see S1).
2.6.2.5. Improvement of (internal) biosecurity and management
(BSM). Since measures take place in all farm parts simultaneously,
contrary to all previous strategies they are assumed to become eﬀective
roughly at the same point in time for all farm parts, at around 3 months,
corresponding to the duration of one fattening period. This results in 40
new batches weaned, 41 new nursery batches and 41 new batches sold
for slaughter in the ﬁrst year in scenario 2.
Extra costs are the expenses related to improvements in biose-
curity and management and are the same as costs in the ﬁnal status
(details on calculations in S1).
2.6.2.5.1. BSM in combination with the vaccination protocols
(MS+BSM, MS+ piglets+ BSM). The change from old to new
batches is as described for the vaccinations.
Extra costs comprise expenses for BSM as under 5) plus the costs for
vaccination (3) and 4).
So, to sum up, for the elimination procedures, most costs incur
during the transition period and only the costs for permanently in-
creasing biosecurity incur throughout the whole period of observation
after completing the intervention. In contrast, for the vaccination
strategies and the strategies relying on improvement of biosecurity
costs incur on a regular basis throughout the whole period of ob-
servation.
2.7. Calculation of the expected value
With the results from partial budget analyses for transition period
and ﬁnal status, investment appraisals are performed to calculate the
net present value, which is the total beneﬁt or loss from the interven-
tion, for each intervention strategy over an observation period of 5
years, at an annual discount rate of 3% (Alarcon et al., 2013). This net
present value is then multiplied by the probability of success and re-
presents the expected value (EV) for each intervention strategy (Eq.
(3)):
∑
∑
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Where:
• EVi is the expected value of the intervention i and reﬂects the total
beneﬁt or losses of the intervention in the 5 year period in-
vestigated.
• NVPBA( )i year0 refers to the net value of the partial budget analysis at
day 1 of the intervention i. It therefore indicates the sum of extra
cost and beneﬁt obtained at the start of the model; or the quantity of
cash needed (or beneﬁt obtained) on day 1 to implement the in-
tervention.
• n is the year, the transition period lasts 1 or 2 years, the ﬁnal period
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last 3 or 4 years
• −NVPBA r(( ) /(1 ) )i n n refers to the net value of the partial budget
analysis done in year n of the intervention, accounting for an annual
discount rate (r). It indicates the value of extra costs and beneﬁts
associated to the implementation of the intervention and obtained
during year n of the transition period.
• Psuccess is the probability (%) that an intervention strategy is suc-
cessful in improving the farm situation as anticipated (diﬀerent from
100% only for 2) C&R).
Furthermore, in addition to the expected value, payback period,
interest rate of return (IRR) and beneﬁt-cost ratio (BCR) were estimated
for each intervention. The payback period indicates the numbers of
years until the costs of an intervention are covered by their beneﬁts,
based on the annual cash ﬂow after the intervention. The IRR indicates
the interest rate at which the cash ﬂow of an intervention does not
generate any beneﬁt or losses. The BCR indicates how much beneﬁt is
obtained per one euro expended on the intervention. Lastly, the relative
rank of each intervention according to the expected value is indicated
for each disease/farm scenario.
2.8. Stochasticity, sensitivity analysis and model validation
To allow for variability and/or uncertainty in the model, stochas-
ticity was included using @RISK software for Excel version 6.3.1
(Palisade Corporation, Newﬁeld, New York, USA): for parameters with
known variability or presenting some degree of uncertainty, PERT
distributions were ﬁtted, and model outputs are presented as median
values and their 90% prediction intervals. Stochastic simulations were
performed with 10,000 iterations. To determine the impact of input
parameters on the ﬁnal outputs, a sensitivity analysis was conducted,
based on the example of farm scenario 1: For strategy 1)–5) separately,
disease parameters, general farm costs and the costs and parameters
listed in Tables 3 and 4 were varied from their 1st to 99th percentile
(variables with stochastic distributions) or from −10% to +10% of
their current value (static variables). Subsequently, the changes in the
EV’s were recorded. Additionally, the impact of the assumed values for
degree of improvement in disease and performance parameters on
model outcomes was assessed: Here, since it was assumed that the
general tendency in terms of impact on EV would be the same for all
intervention strategies, strategy 4) MS+piglets was chosen as re-
presentative example. Improvement parameters were again varied from
their 1st to 99th percentile and changes in EV recorded (presented as
tornado graph, Supplementary material S3). The model and its results
were validated via extensive review by three experts with vast PRRSV
control and elimination ﬁeld experience.
3. Results
The results of partial budget analyses of the transition phase for the
seven diﬀerent intervention strategies and ﬁve diﬀerent farm and dis-
ease scenarios are shown in
Table 5 The same table also indicates the annual gross margin to be
expected for each strategy after its completion. The net value (NVPBA)
during the transition phase was negative for D/R in all ﬁve scenarios.
For all other intervention strategies, net values during transition were
positive. The estimated gross margins, denoted by revenue minus
variable costs, were highest for the elimination strategies, regardless of
the scenario. The median expected values (EV) over ﬁve years for the
diﬀerent scenarios and each strategy are presented in Figs. 1–5 and
Table 6, the latter also indicating payback period, IRR, BCR and rank.
In scenario 1, a farrow-to-ﬁnish herd slightly aﬀected in all farm
parts, MS+ piglets exhibited the highest EV: the median was € 721′745,
and in 90% of the simulations, the result was between € 604′121 and €
847′150 (5%ile and 95%ile). The lowest, i.e. a negative EV, had D/R
(Fig. 1). This was further shown by the entirely negative cash ﬂow over
all ﬁve years for D/R, whereas the vaccination strategies and BSM
yielded positive cash ﬂows from the ﬁrst year onwards (Fig. 6). If the
same farrow-to-ﬁnish herd was moderately aﬀected in all farm parts,
like in scenario 2, EVs were generally higher and 2) C&R became the
intervention strategy with the highest EV, followed by 4) sow and piglet
vaccination (Fig. 2, Table 6). If (scenario 3) the farrow-to-ﬁnish herd
already did sow mass vaccination but was moderately aﬀected in nur-
sery and fattening, the EV’s were overall lower than in the previous
examples. The highest EV yielded C&R, followed by MS+piglets,
whereas the strategy with the lowest median EV, D/R, yielded almost
no positive cash-ﬂow, the 90% including interval covering negative
values (Fig. 4, Table 6). In the case of a herd that does not have fat-
tening pigs like the breeding herd in scenario 4, which is moderately
aﬀected in breeding only, MS yielded the highest median EV. The next
highest value was estimated for BSM, whereas elimination strategies
had the lowest EV’s (Fig. 4 and Table 6). If the breeding herd was al-
ready vaccinating sows but was still slightly aﬀected in breeding and
nursery almost equally high EV’s were estimated for MS+piglets and
BSM (Fig. 5, Table 6).
In all scenarios, the 90% prediction intervals were generally larger
for elimination strategies than for the other strategies. The BCR’s were
in most cases higher in the breeding than in the farrow-to-ﬁnish herd
scenarios and highest for vaccination strategies. Combinations of BSM
and vaccination usually obtained lower median EV’s than vaccinations
or BSM alone. The cost variables that caused the largest variation in EV,
if varied themselves, were the additional biosecurity costs for the
elimination strategies, and the received price per kg live weight of a
slaughter pig for the other strategies, the latter being the second most
important also for eliminations. In addition, feed costs had an im-
portant impact in most strategies (supplementary material S3). In terms
of improvement in disease and performance parameters, (1) the as-
sumed reduction in weaners’ mortality, (2) the assumed increase in the
number of piglets born alive per sow per litter, and the assumed de-
crease in fatteners’ mortality had the largest impact on EV’s at their
current ranges. This can be seen in the sensitivity tornado in S3 for
MS+piglets (the broader the bar, the larger the impact of each vari-
able).
4. Discussion
The study aimed to evaluate the economic eﬃciency of seven
common PRRSV intervention strategies for ﬁve diﬀerent farm and
disease situations over a period of ﬁve years, using an economic si-
mulation model. The two most commonly applied elimination strate-
gies, D/R and C&R were considered. The costly test & removal strategy
is rarely applied for PRRSV control and was therefore not considered in
this manuscript. Furthermore, although various diﬀerent vaccination
protocols are in use, herein we focused on protocols based on 3-monthly
mass vaccination of sows. Costs for other schemes (“6/60”: vaccination
of each sow six days after every farrowing and at day 60 of every ge-
station; included in the calculation tool) did not diﬀer substantially.
Simulation models have been successfully used to address various
aspects of PRRSV infection and epidemiology: A stochastic transmission
model developed by Rovira et al. (2007) simulated the time to detection
of a PRRSV outbreak in a boar stud with diﬀerent monitoring protocols.
Other within-herd transmission models examined the patterns of on-
farm persistence and fade-out (Evans et al., 2010) or control strategies
against PRRSV (Jeong et al., 2014). Farm-level models were built to
model contact structures and between-herd transmission (Amirpour
Haredasht et al., 2017; Lee et al., 2017; Thakur et al., 2015a,b), as well
as ways to prevent airborne transmission (Dee et al., 2010), or to
evaluate diﬀerent regional surveillance strategies (Arruda et al., 2017).
There are even mathematical models simulating the interactions be-
tween PPRSV and immunological structures and processes within a
pig’s body (Go et al., 2014). However, to the author’s knowledge, the
model presented herein is the ﬁrst simulation tool to assess the
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economic eﬃciency of intervention strategies in an endemically
PRRSV-infected herd.
The expected values, indicating the extra amount of money gener-
ated by the diﬀerent intervention strategies, varied considerably be-
tween, and also within the diﬀerent disease and farm scenarios. They
were generally higher in more severely aﬀected scenarios than in less
severely aﬀected scenarios. In the presented scenarios and with the
prices used, vaccination strategies were more proﬁtable if the farm was
only slightly aﬀected, whereas elimination strategies became more
beneﬁcial if the farm was more severely aﬀected. The reason is that
elimination strategies were more costly than other strategies, so that
ﬁnancial eﬀorts were outweighed only if the expected improvement in
performance was high enough, as could be expected for more severely
aﬀected farms. Among the elimination strategies, C&R always had the
highest EV, whereas D/R in some scenarios did not yield any signiﬁcant
beneﬁt within ﬁve years. The reason for this ﬁnding is that D/R, albeit
being the most eﬀective measure, is at the same time the most costly
strategy of all, as could be concluded from the negative partial budgets
during transition, the long payback periods and negative cash ﬂow.
Nevertheless, these calculations apply for the “traditional” D/R scheme
considered herein, where unbred gilts are purchased, leading to a long
time period without production. Modiﬁed schemes with external
raising and mating of replacement gilts could shorten the time period
without production and associated costs. This would make the strategy
D/R more attractive from an economical perspective, and such a
modiﬁed scheme could be considered in the continued development of
the model/tool. In contrast, C&R is a relatively cheap strategy. This is in
line with calculations for US breeding herds, in which the payback
period for C&R was often between half a year and one year, whereas for
D/R it ranged from 1.5 to more than ﬁve years (Holtkamp et al., 2012).
This makes C&R an interesting option, provided that it is successful and
feasible from a practical point of view. In most reports of successful
elimination via C&R, it was applied to breeding herds or herds with
segregated oﬀ-site production with no growing pigs present (Desrosiers
and Boutin, 2002; Linhares et al., 2014). It might be less easily at-
tainable in farrow-to-ﬁnish farms, although examples of successful
elimination exist (Štukelj et al., 2015). Furthermore, before considering
this strategy, it needs to be checked whether the space capacity on the
farm allows for such a strategy.
When interpreting results it should be considered that EV’s reﬂect
the farm’s beneﬁts, provided that the farm conditions remain the same
for the whole observation period. This is not only conﬁned to general
farm settings like prices; and especially feed prices and slaughter prices,
which had a very high impact on the outcome, have been subject to
strong ﬂuctuation in the past (Rocadembosch et al., 2016). It also re-
lates to the PRRSV status of the herd, implying that after elimination
strategies a herd remains PRRSV-negative. This is a strong assumption,
especially in pig dense areas like The Netherlands or north-western
Germany, where the risk of re-infection is considered high (Fahrion
et al., 2014). This problem of densely pig-populated areas was
Table 5
Median partial budgets of the transition period (ﬁrst year after start of the intervention, for D/R also second year) and median annual gross margins of the ﬁnal status (from second (D/R
third) year after start of the intervention) for seven diﬀerent intervention strategies and ﬁve diﬀerent farm and disease scenarios (negative values in italic).
Scenario
Intervention 1 2 3 4 5
Partial budget transition (median)
1. D/R 1st year € −195.673,02 € −128.264,96 € −186.349,00 € −122.061,06 € −152.072,80
1. D/R 2nd year € −285.536,62 € −144.712,51 € −246.544,35 € 91.678,88 € 68.714,07
2. C&R € 39.023,88 € 34.752,61 € 30.548,92 € 68.594,13 € 61.381,87
3. MS € 131.193,88 € 117.472,94 not applicable € 126.951,57 not applicable
4. MS+piglets € 141.940,45 € 137.274,08 € 96.428,28 € 112.003,61 € 96.493,15
5. BSM € 196.846,43 € 213.324,50 € 123.186,59 € 117.575,42 € 96.930,88
6. MS+BSM € 77.313,26 € 73.123,67 € 0,00 € 104.531,21 € 0,00
7. MS+piglets+ BSM € 74.051,79 € 83.321,29 € 35.467,83 € 89.650,16 € 73.247,87
Gross margin ﬁnal status (median)
1. D/R; 2. C&R € 734.831,46 € 750.780,41 € 727.880,50 € 339.601,03 € 364.117,07
3. MS € 657.097,76 € 556.110,07 not applicable € 326.833,82 not applicable
4. MS+piglets € 670.706,80 € 577.425,04 € 567.205,72 € 304.152,59 € 324.575,36
5. BSM € 692.549,61 € 597.380,71 € 584.701,86 € 329.854,59 € 343.431,32
6. MS+BSM € 694.544,47 € 619.936,38 not applicable € 333.942,33 not applicable
7. MS+piglets+ BSM € 686.671,48 € 625.879,75 € 604.490,18 € 311.011,47 € 331.767,83
Fig. 1. Median expected value per intervention scenario for scenario 1, farrow-to-ﬁnish herd, no previous vaccination, slightly aﬀected in all farm parts, no virus detected.
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conﬁrmed by a US-study, in which 40% of 33 observed breeding herds
became PRRSV-positive within the ﬁrst year after being established
PRRSV-free (Holtkamp et al., 2010). In this model, however, we
decided not to consider this risk of re-infection, since it would have
further inﬂated the complexity of the model. Furthermore, it would
have required substantiated estimates of the annual probability of re-
introduction, which is as such very much dependent on various herd
individual but also regional factors. Thus, to make the model useable
for all diﬀerent farms and regions, we would have had to use an ex-
tremely broad-ranged probability distribution, rendering the resulting
estimate almost uninformative. Another observation from the calcu-
lated scenarios is that prediction intervals for elimination strategies
were usually larger than for the others, indicating a higher degree of
uncertainty in the estimation. In scenario 2, although C&R had a higher
median EV, the 5%ile was higher for MS+piglets or BSM.
Summarizing the above, the most appropriate intervention for a
farm depends on the farmer’s willingness to invest into PRRSV control
and the return on investment and level of risk which is acceptable to
his/him: elimination strategies should only be considered for farms
with a suﬃciently comfortable ﬁnancial background, which can bear
higher degrees of uncertainty and the relatively high costs at the be-
ginning of the intervention. Otherwise, vaccination strategies are a
more predictable alternative in their long-term beneﬁts. Certainly, their
eﬀect on disease and performance depends on many factors, to mention
only the PRRSV strain circulating in the farm, type of vaccine or pre-
sence of co-infections. These speciﬁc inﬂuences could not be accounted
for, because this would have made the model too complex, or no data
were available. However, this variation was covered by including sto-
chasticity in the model, to account for uncertainty or variability. One of
the advantages of vaccinations is that they do not require huge expenses
at the beginning of the intervention, because costs incur on a regular
basis. Moreover, the risk of re-infection does not play such an important
role, or more explicitly, vaccinations are especially economic in cases of
frequent re-infection with ﬁeld virus (Linhares et al., 2015).
In most scenarios, combined vaccination of sows and piglets held
advantage over sow vaccination alone. Even if sows had already been
vaccinated, additional piglet vaccination yielded an additional ﬁnancial
beneﬁt. Only in one scenario where just the breeding part was aﬀected,
sow vaccination alone was more beneﬁcial compared to sow and piglet
vaccination. This seems reasonable, as in a herd with PRRSV problems
only in sows, targeting these sows directly is likely to lead to the most
prominent improvement. The strategy of BSM yielded EV’s that were
often similar to those of vaccinations, but was never ranked top. One
reason for this was certainly that we assumed quite high costs for this
strategy in the presented scenarios, so that the expected improvement
did not outweigh these costs. The results might be diﬀerent with lower
assumed costs (as underpinned by sensitivity analysis where they had
an important impact on the outcome). For the same reason, combined
strategies of BSM and vaccinations did not yield a high EV either. It can
be argued that the way how BSM was modelled was fairly crude, be-
cause no distinction between individual measures was made. Here
again, the reason was that it would have caused an excess in complexity
of the model; and since information found on the expected improve-
ment in disease and performance of individual measures was scarce, it
Fig. 2. Median expected value per intervention scenario for scenario 2, farrow-to-ﬁnish herd, no previous vaccination, moderately aﬀected in all farm parts, virus detected.
Fig. 3. Median expected value per intervention scenario for scenario 3, farrow-to-ﬁnish herd, previously sow mass vaccination every three months, moderately aﬀected in nursery and
fattening, virus detected.
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would not have contributed to the accuracy of the model’s estimates.
Nevertheless, a good biosecurity is an important part in the control of
PRRS as well as other infectious diseases.
In general, it must be pondered that the described results are valid
for the indicated farm structures, prices etc. In other countries with
diﬀerent structures, outcomes might diﬀer completely. Especially prices
show a strong variation between countries, some like labour costs even
between individual farms. In particular, prices for feed, pigs and labour
had a high impact on the proﬁtability of the strategies according to
sensitivity analysis. This seems reasonable as these costs generally
contribute the most to the farm budget (Linhares et al., 2015;
Rocadembosch et al., 2016). Also, the presented scenarios are only a
small and arbitrary selection of all possible constellations of farm type,
farm parts aﬀected or disease severity, and it was impractical to cover
the whole range of possible scenarios, which might have yielded other
results. Regarding herd stability, we could not stick to the strict inter-
pretation of Holtkamp categorization. This is for practical reasons, be-
cause we assume that users, at the time of using the model, have in
many cases not made suﬃcient diagnostics to substantiate a stable herd
status. Thus, the fact that no virus has been detected in a herd is not a
proof of its stability, but can only serve as a hint that PRRSV circulation
in this herd was at somewhat lower levels. This does not preclude a
slight clinical impact of the virus. Moreover, the model was speciﬁcally
designed for PRRS, as changes in productivity and health parameters
are used to model the impact of and losses due to PRRS. This implies
that the obtained results are only informative if PRRSV is the (main)
cause of disease in the farm, which should be conﬁrmed a priori by
laboratory diagnosis. Likewise, co-infections are not speciﬁcally ac-
counted for in the model, because this again would unnecessarily in-
ﬂate its complexity, but the potential need for their control should be
given consideration in the weighing of interventions. An advantage of
D/R is that other infectious agents present in the herd can be eliminated
at the same time, and many BSM measures have a positive eﬀect not
only on PRRSV but also many other infectious diseases. Besides, due to
the interaction of PRRSV with various pathogens (Zimmerman et al.,
2012), its control as such can have a beneﬁcial eﬀect on the clinical
presentation of other diseases.
A general limitation of all models is that in the face of insuﬃcient
data on model parameters, several assumptions have to be made. Since
only little information could be found especially on the eﬀect of vac-
cination or biosecurity measures on several disease and performance
parameters, estimates from an expert poll were used. While so-derived
data usually obtain a satisfactory reliability (Dorussen et al., 2005), the
limited number of experts might be associated with some uncertainty.
The use of stochasticity somewhat resolves this uncertainty. Besides
input parameters, also the structure of the model itself is based on as-
sumptions. For instance, the modelling of the transition phase (in par-
ticular the abrupt change from “old” to “new” status) is a strong sim-
pliﬁcation, as in real life improvement would happen more gradually.
However, since the period of observation is long, this inaccuracy in the
ﬁrst months is deemed to be of minor relevance for the overall outcome.
Nevertheless, to gain more certainty about input parameters and model
outcomes, the model shall be validated in a ﬁeld study.
If these issues are considered, the model can serve as a valuable tool
Fig. 4. Median expected value per intervention scenario for scenario 4, breeding herd, no previous vaccination, moderately aﬀected in breeding part, virus detected.
Fig. 5. Median expected value per intervention scenario for scenario 5, breeding herd, previously sow mass vaccination every three months, slightly aﬀected in breeding and nursery, no
virus detected.
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in the decision-making process of farmers and veterinarians on the most
suitable intervention strategy. Although many strategies are eﬀective
against PRRS, not all of them have been proven to be equally eco-
nomically eﬃcient in all cases, and until to date the long-term beneﬁts
of a strategy in a given farm situation were speculative. As Fraile (2012)
reminded emphatically, a cost-beneﬁt-analysis should be an integral
part before implementing any control or eradication measure for live-
stock diseases. The present model gives quantitative estimates to
project the long-term beneﬁts of a strategy for a speciﬁc farm setting
and thus enables a better informed decision. Although the model has
been designed for PRRSV, due to its modular structure it can be adapted
with little eﬀort for the evaluation of other diseases.
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Table 6
Summary of economic outputs for each intervention strategy and all scenarios, including the expected value (EV), the payback period, the interest rate of return (IRR), the beneﬁt-cost
ratio (BCR) and each strategy‘s rank based on its median EV (negative values in italic).
Scenario
Intervention 1 2 4 4 5
1) D/R
EV median € −8′603 € 800′003 € 6′829 € 434′396 € 313′165
EV 5%ile € −254′799 € 570′383 € −233′750 € 322′052 € 191′874
EV 95%ile € 164′673 € 966′150 € 164′527 € 533′710 € 419′506
Payback period > 5years 3 years 5years 3 years 3 years
Median IRR n.c.a 0.840 0.006 1.022 0.632
Median BCR 0.998 1.149 1.001 1.327 1.246
Rank 7 7 5 6 5
2) C&R
EV median € 489′004 € 1′126′807 € 485′214 € 511′951 € 431′505
EV 5%ile € 270′389 € 785′252 € 266′604 € 352′659 € 289′776
EV 95%ile € 694′185 € 1′396′677 € 685′379 € 652′384 € 569′592
Payback period < 1year < 1year < 1year <1year < 1year
Median IRR n.c.a n.c.a n.c.a n.c.a n.c.a
Median BCR 1.654 1.677 1.746 3.169 3.858
Rank 4 1 1 7 3
3) MS
EV median € 664′111 € 1′021′527 strategy not applicable € 746′463 strategy not applicable
EV 5%ile € 568′114 € 832′760 € 592′551
EV 95%ile € 771′887 € 1′212′381 € 849′454
Payback period < 1year < 1year <1year
Median IRR 66.57 60.62 64.67
Median BCR 1.876 1.668 4.864
Rank 2 4 1
4) MS+piglets
EV median € 721′745 € 1′114′649 € 332′296 € 650′271 € 535′244
EV 5%ile € 604′121 € 901′690 € 200′459 € 500′656 € 425′314
EV 95%ile € 847′150 € 1′326′905 € 515′102 € 756′133 € 649′562
Payback period < 1year < 1year < 1year <1year < 1year
Median IRR 72.01 70.483 n.c.a 57.256 n.c.a
Median BCR 1.886 1.700 1.999 3.637 5.258
Rank 1 2 2 3 1
5) BSM
EV median € 602′060 € 1′032′336 € 167′253 € 674′879 € 528′463
EV 5%ile € 465′349 € 806′016 € 27′430 € 520′580 € 410′700
EV 95%ile € 733′198 € 1′252′563 € 362′625 € 775′536 € 643′155
Payback period < 1year < 1year < 1year <1year < 1year
Median IRR n.c.a n.c.a n.c.a n.c.a n.c.a
Median BCR 1.539 1.532 1.321 3.297 3.857
Rank 3 3 3 2 2
6) MS+BSM
EV median € 453′116 € 940′482 strategy not applicable € 645′134 strategy not applicable
EV 5%ile € 342′926 € 767′134 € 567′265
EV 95%ile € 565′710 € 1′130′422 € 736′972
Payback period < 1year < 1year <1year
Median IRR 39.82 39.34 53.53
Median BCR 1.390 1.452 2.877
Rank 5 6 4
7) MS+piglets+BSM
EV median € 422′274 € 970′174 € 114′796 € 547′718 € 426′632
EV 5%ile € 309′028 € 788′003 € −49′023 € 469′754 € 322′368
EV 95%ile € 534′698 € 1′169′939 € 293′501 € 640′047 € 534′310
Payback period < 1year < 1year < 1year <1year < 1year
Median IRR 38.20 44.202 n.c.a 46.060 n.c.a
Median BCR 1.341 1.443 1.134 2.380 2.604
Rank 6 5 4 5 4
a n.c. = IRR is not always possible to calculate (e.g. if there are only beneﬁts and no costs or vice versa).
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